# NasoShield Study of Safety and Immunogenicity

> **NCT03352466** · PHASE1 · COMPLETED · sponsor: **Altimmune, Inc.** · enrollment: 145 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** NasoShield
- **BIOLOGICAL:** BioThrax
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03352466
- **Lead sponsor:** Altimmune, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-18
- **Primary completion:** 2019-05-13
- **Final completion:** 2019-05-13
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03352466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03352466, "NasoShield Study of Safety and Immunogenicity". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03352466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*